Callan JMB Received Notice of Delisting

Callan JMB Inc. (NASDAQ:CJMB) shares rose about 49.8% to $1.29 after hours after the company said it signed a strategic partnership with Alabama State University to build an integrated pharmaceutical manufacturing ecosystem. Callan will provide logistics and regulatory support and receive 21% of qualifying gross revenue. Management projected annual gross revenues near $500 million, about $105 million for the company. The stock also faces a Nasdaq $1 bid compliance deadline.

Berkshire Hathaway, led by Greg Abel, increased investments in Alphabet and Delta Air Lines, and repurchased $4.5 billion of its own stock in Q2. Abel's strategy aligns with Buffett's value-focused approach, with Berkshire holding $359.2 billion in cash and short-term investments post-purchases. Berkshire's buybacks follow a rule where shares are repurchased only when below intrinsic value, with average prices of $476.01 in May and $487.98 in June.

AT&T (T) is selling its wireless business in Mexico and eliminating the role of its global marketing officer, Lori M. Lee, as part of a strategic shift to streamline its international operations. The changes reflect efforts to reconfigure its global strategy and may impact its competitive position in Latin America.

TD Cowen raised its price target for Strive, Inc. (ASST) to $56 from $44, citing faster Bitcoin (BTC) accumulation. Strive's BTC holdings grew to 35,595, exceeding estimates. The company issued $630M in preferred shares to fund purchases, maintaining a debt-free balance sheet. Analysts highlight the strategy of financing via preferred equity to grow BTC holdings without issuing common stock.

Israeli software company monday.com (MNDY) expects several senior management departures amid a restructuring and shift to AI-powered work platforms. The company announced a 20% workforce reduction in July, with restructuring costs estimated at $45M-$55M. Q2 2026 revenue was $364.6M, up 22% YoY, with net profit at $3.46M. Shares closed at $90, down 4% on the day and 37% YTD.

IonQ's stock fell 13.76% after announcing a $2 billion equity and warrant financing deal. The offering, priced at $40 per unit, includes anti-dilution protections and warrants exercisable at $69.46. Analysts cut price targets, with Rosenblatt reducing its target to $70 and Morgan Stanley to $43, citing dilution concerns. Despite the drop, options data show call buying outpacing puts, and the company is advancing its quantum computing roadmap.